Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.1291
-0.0031 (-2.34%)
At close: Dec 5, 2025, 4:00 PM EST
0.1269
-0.0022 (-1.70%)
After-hours: Dec 5, 2025, 7:57 PM EST
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.67 million as of December 5, 2025. Its market cap has decreased by -50.55% in one year.
Market Cap
2.67M
Enterprise Value
-800.39K
1-Year Change
-50.55%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $2.67M, a decrease of -89.81%. That is a compound annual growth rate of -41.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.73M | -54.84% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 927.06B |
| Johnson & Johnson | 495.23B |
| AbbVie | 405.88B |
| UnitedHealth Group | 306.79B |
| AstraZeneca | 282.37B |
| Novartis AG | 257.47B |
| Merck & Co. | 254.98B |
| Thermo Fisher Scientific | 220.36B |